CTNS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.296900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.249500E-02
Normal-vs-Stage2
8.741600E-03
Normal-vs-Stage3
5.596400E-03
Normal-vs-Stage4
5.024300E-02
Stage1-vs-Stage2
7.092400E-01
Stage1-vs-Stage3
4.496800E-01
Stage1-vs-Stage4
9.700200E-01
Stage2-vs-Stage3
2.436600E-01
Stage2-vs-Stage4
7.959200E-01
Stage3-vs-Stage4
4.379800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.203560E-02
Normal-vs-AfricanAmerican
1.091640E-02
Normal-vs-Asian
5.224800E-03
Caucasian-vs-AfricanAmerican
8.043200E-01
Caucasian-vs-Asian
6.673800E-01
AfricanAmerican-vs-Asian
5.051800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.282750E-03
Normal-vs-Female
4.270100E-02
Male-vs-Female
9.374400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.401380E-01
Normal-vs-Age(41-60Yrs)
7.628100E-02
Normal-vs-Age(61-80Yrs)
1.281090E-03
Normal-vs-Age(81-100Yrs)
3.231900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.716000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.531000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.955400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.687790E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.241200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.075600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.764800E-04
Normal-vs-Daily Drinker
5.737100E-03
Normal-vs-Weekly Drinker
4.777600E-01
Normal-vs-Occasional Drinker
3.939000E-03
Normal-vs-Social Drinker
8.026000E-02
Non Drinker-vs-Daily Drinker
8.717600E-01
Non Drinker-vs-Weekly Drinker
6.730500E-02
Non Drinker-vs-Occasional Drinker
4.408800E-01
Non Drinker-vs-Social Drinker
6.703600E-03
Daily Drinker-vs-Weekly Drinker
8.614300E-02
Daily Drinker-vs-Occasional Drinker
6.146000E-01
Daily Drinker-vs-Social Drinker
3.096000E-02
Weekly Drinker-vs-Occasional Drinker
1.369150E-01
Weekly Drinker-vs-Social Drinker
6.456800E-01
Occasional Drinker-vs-Social Drinker
6.817900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.624600E-01
Normal-vs-Grade 2
6.453600E-01
Normal-vs-Grade 3
6.531400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.558800E-01
Grade 1-vs-Grade 3
7.053200E-01
Grade 1-vs-Grade 4
6.624600E-01
Grade 2-vs-Grade 3
6.198600E-01
Grade 2-vs-Grade 4
6.453600E-01
Grade 3-vs-Grade 4
6.531400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.738300E-03
Normal-vs-NonDiabetic
1.681810E-02
Diabetic-vs-NonDiabetic
4.146600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.939700E-02
Normal-vs-NoPancreatitis
1.256130E-02
Pancreatitis-vs-NoPancreatitis
9.729200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.716500E-03
Normal-vs-N1
1.034230E-02
N0-vs-N1
9.412200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.258090E-02
Normal-vs-TP53-NonMutant
2.510100E-02
TP53-Mutant-vs-TP53-NonMutant
2.186300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
